Third Arc Bio
Boston · Founded 2022
About Third Arc Bio
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases. Its drug development engine delivers superior biologics optimized to create T-cell engagement by leveraging two technologies that power a pipeline of high-value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $217.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2026)
- Website: https://thirdarcbio.com
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/third-arc-bio-97094 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.